Preface
Spotlight on circulating tumour cells
Translational Lung Cancer Research
2017;
6
(4)
:396
.
(24 August 2017)
Review Article
Circulating tumor cells and CDX models as a tool for preclinical drug development
Translational Lung Cancer Research
2017;
6
(4)
:397-408
.
(24 August 2017)
The clinical utility of circulating tumour cells in patients with small cell lung cancer
Translational Lung Cancer Research
2017;
6
(4)
:409-417
.
(24 August 2017)
Circulating tumor cell interactions with macrophages: implications for biology and treatment
Translational Lung Cancer Research
2017;
6
(4)
:418-430
.
(24 August 2017)
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
Translational Lung Cancer Research
2017;
6
(4)
:431-443
.
(24 August 2017)
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?
Translational Lung Cancer Research
2017;
6
(4)
:444-453
.
(24 August 2017)
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
Translational Lung Cancer Research
2017;
6
(4)
:454-472
.
(24 August 2017)
Biophysical technologies for understanding circulating tumor cell biology and metastasis
Translational Lung Cancer Research
2017;
6
(4)
:473-485
.
(24 August 2017)
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Translational Lung Cancer Research
2017;
6
(4)
:486-498
.
(24 August 2017)
Disclosure:
The focused issue “Current Knowledge and Future Perspectives on Circulating Tumor Cells in Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Fiona Blackhall and Caroline Dive served as the unpaid Guest Editors for the focused issue.
